keyword
https://read.qxmd.com/read/38651900/a-dual-fluorescent-herpes-simplex-virus-type-1-recombinant-reveals-divergent-outcomes-of-neuronal-infection
#1
JOURNAL ARTICLE
Luke F Domanico, Gary P Dunn, Oren Kobiler, Matthew P Taylor
Critical stages of lytic herpes simplex virus type 1 (HSV-1) replication are marked by the sequential expression of immediate early (IE) to early (E), then late (L) viral genes. HSV-1 can also persist in neuronal cells via a non-replicative, transcriptionally repressed infection called latency. The regulation of lytic and latent transcriptional profiles is critical to HSV-1 pathogenesis and persistence. We sought a fluorescence-based approach to observe the outcome of neuronal HSV-1 infection at the single-cell level...
April 23, 2024: Journal of Virology
https://read.qxmd.com/read/38651899/harnessing-the-power-of-ifn-for-therapeutic-approaches-to-covid-19
#2
REVIEW
Elise G Viox, Steven E Bosinger, Daniel C Douek, Gideon Schreiber, Mirko Paiardini
Interferons (IFNs) are essential for defense against viral infections but also drive recruitment of inflammatory cells to sites of infection, a key feature of severe COVID-19. Here, we explore the complexity of the IFN response in COVID-19, examine the effects of manipulating IFN on SARS-CoV-2 viral replication and pathogenesis, and highlight pre-clinical and clinical studies evaluating the therapeutic efficacy of IFN in limiting COVID-19 severity.
April 23, 2024: Journal of Virology
https://read.qxmd.com/read/38651898/murine-norovirus-mutants-adapted-to-replicate-in-human-cells-reveal-a-post-entry-restriction
#3
JOURNAL ARTICLE
Melissa R Budicini, Valerie J Rodriguez-Irizarry, Robert W Maples, Julie K Pfeiffer
UNLABELLED: RNA viruses lack proofreading in their RNA polymerases and therefore exist as genetically diverse populations. By exposing these diverse viral populations to selective pressures, viruses with mutations that confer fitness advantages can be enriched. To examine factors important for viral tropism and host restriction, we passaged murine norovirus (MNV) in a human cell line, HeLa cells, to select mutant viruses with increased fitness in non-murine cells. A major determinant of host range is expression of the MNV receptor CD300lf on mouse cells, but additional host factors may limit MNV replication in human cells...
April 23, 2024: Journal of Virology
https://read.qxmd.com/read/38651897/the-traf3-dyrk1a-rad54l2-complex-maintains-ace2-expression-to-promote-sars-cov-2-infection
#4
JOURNAL ARTICLE
Dexin Mao, Shufeng Liu, An Thanh Phan, Stephanie Renner, Yan Sun, Tony T Wang, Yiping Zhu
UNLABELLED: Angiotensin converting enzyme 2 (ACE2), the host receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is differentially expressed in a wide variety of tissues and cell types. The expression of ACE2 is under tight regulation, but the mechanisms regulating ACE2 expression have not yet been well defined. Through a genome-wide CRISPR knockout screen, we discovered that host factors TRAF3, DYRK1A, and RAD54L2 (TDR) form a complex to regulate the expression of ACE2...
April 23, 2024: Journal of Virology
https://read.qxmd.com/read/38651670/efficacy-of-antiviral-therapy-for-the-prevention-of-mother-to-child-transmission-of-hepatitis%C3%A2-b-virus-and-the-risk-of-postpartum-hepatitis-flare-after-discontinuation-of-antiviral-therapy
#5
Hayato Kawamura, Kentaro Matsuura, Koichi Ito, Tokio Sugiura, Takanori Suzuki, Kei Fujiwara, Hiromi Kataoka, Yasuhito Tanaka
The use of nucleos(t)ide analogs (NAs) is recommended for mothers with a high viral load of hepatitis B virus (HBV) during the second or third trimester of pregnancy. However, postpartum hepatitis flares can occur in some cases. We examined the efficacy of NA administration for the prevention of mother-to-child transmission of hepatitis B virus, and evaluated the risk of postpartum hepatitis flares in mothers after NA discontinuation. Nine pregnant women with a high viral load (HBV DNA ≥5.3 log IU/mL) received tenofovir disoproxil fumarate (TDF) at approximately 28 weeks of gestation, and TDF was discontinued at 4-10 weeks after delivery...
April 23, 2024: Hepatology Research: the Official Journal of the Japan Society of Hepatology
https://read.qxmd.com/read/38650361/safety-immunogenicity-and-protective-effective-of-inhaled-covid-19-vaccines-a-systematic-review-and-meta-analysis
#6
REVIEW
Gao Song, Rong Li, Meng-Qun Cheng
This study aimed to examine the safety, immunogenicity and protective effective of inhaled COVID-19 vaccines (ICVs). Literature research was done through EMBASE, Cochrane, PubMed, and Web of Science up to 10 March 2024. Pooled estimates with corresponding 95% confidence intervals (CI) were computed and compared using the random effects and common effects model. Of the 15 studies, 11 analyzed safety, 13 analyzed immunogenicity, and 3 analyzed protective effective. The results showed a favorable safety profile of ICVs for primary vaccination series, however it does not always seem to produce the expected immune response and protective effective...
April 2024: Journal of Medical Virology
https://read.qxmd.com/read/38649070/validation-of-a-severe-acute-respiratory-syndrome-coronavirus-2-microneutralization-assay-for-evaluation-of-vaccine-immunogenicity
#7
JOURNAL ARTICLE
Stephanie Hamilton, Mingzhu Zhu, Shane Cloney Clark, Penny Mayes, Jen Fenner, Leah Cui, Rongman Cai, Raj Kalkeri, Louis F Fries, Melinda Pryor, Joyce Plested
As variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to emerge, assessment of vaccine immunogenicity remains a critical factor to support continued vaccination. To this end, an in vitro microneutralization (MN50) assay was validated to quantitate SARS-CoV-2 neutralizing antibodies against prototype and variant strains (Beta, Delta, Omicron BA.1, Omicron BA.5, and XBB.1.5) in human serum. For the prototype strain, the MN50 assay met acceptance criteria for inter-/intra-assay precision, specificity, linearity, and selectivity...
April 20, 2024: Journal of Virological Methods
https://read.qxmd.com/read/38649069/heparin-mediated-pcr-interference-in-sars-cov-2-assays-and-subsequent-reversal-with-heparinase-i
#8
JOURNAL ARTICLE
K Edwards, T Corocher, Y Hersusianto, D Campbell, K Subbarao, J A Neil, P Monagle, P Ho
Heparin is postulated to block the interaction of SARS-CoV-2 with highly glycosylated proteins which are critical for binding the angiotensin-converting enzyme 2 (ACE2), an essential mechanism for host-cell entry and viral replication. Intranasal heparin is under investigation for use as a SARS-CoV-2 preventative in the IntraNasal Heparin Trial (INHERIT, NCT05204550). Heparin directly interferes with real-time quantitative polymerase chain reaction (RT-qPCR), the gold standard for SARS-CoV-2 detection. This study aimed to investigate the magnitude of heparin interference across various clinical laboratory testing platforms, and the reversal of any interference by degradation of heparin using the heparinase I enzyme in nasopharyngeal swab (NP) samples for SARS-CoV-2 analysis by RT-qPCR...
April 20, 2024: Journal of Virological Methods
https://read.qxmd.com/read/38647327/a-tetravalent-dengue-virus-like-particle-vaccine-induces-high-levels-of-neutralizing-antibodies-and-reduces-dengue-replication-in-non-human-primates
#9
JOURNAL ARTICLE
Daniel Thoresen, Kenta Matsuda, Akane Urakami, Mya Myat Ngwe Tun, Takushi Nomura, Meng Ling Moi, Yuri Watanabe, Momoko Ishikawa, Trang Thi Thu Hau, Hiroyuki Yamamoto, Yuriko Suzaki, Yasushi Ami, Jonathan F Smith, Tetsuro Matano, Kouichi Morita, Wataru Akahata
Dengue virus (DENV) represents a significant global health burden, with 50% of the world's population at risk of infection, and there is an urgent need for next-generation vaccines. Virus-like particle (VLP)-based vaccines, which mimic the antigenic structure of the virus but lack the viral genome, are an attractive approach. Here, we describe a dengue VLP (DENVLP) vaccine which generates a neutralizing antibody response against all four DENV serotypes in 100% of immunized non-human primates for up to 1 year...
April 22, 2024: Journal of Virology
https://read.qxmd.com/read/38647317/second-correction-for-shin-et-al-histone-deacetylase-classes-i-and-ii-regulate-kaposi-s-sarcoma-associated-herpesvirus-reactivation
#10
JOURNAL ARTICLE
Hye Jin Shin, Jennifer DeCotiis, Mario Giron, Diana Palmeri, David M Lukac
No abstract text is available yet for this article.
April 22, 2024: Journal of Virology
https://read.qxmd.com/read/38647075/simple-sensitive-and-visual-detection-of-12-respiratory-pathogens-with-one-pot-rpa-crispr-cas12a-assay
#11
JOURNAL ARTICLE
Qi Tan, Yaoqiang Shi, Chenlu Duan, Qingyuan Li, Tao Gong, Shilin Li, Xiaoqiong Duan, He Xie, Yujia Li, Limin Chen
Respiratory infections pose a serious threat to global public health, underscoring the urgent need for rapid, accurate, and large-scale diagnostic tools. In recent years, the CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated) system, combined with isothermal amplification methods, has seen widespread application in nucleic acid testing (NAT). However, achieving a single-tube reaction system containing all necessary components is challenging due to the competitive effects between recombinase polymerase amplification (RPA) and CRISPR/Cas reagents...
April 2024: Journal of Medical Virology
https://read.qxmd.com/read/38647071/multi-omics-panoramic-analysis-of%C3%A2-hbv-integration-transcriptional-regulation-and-epigenetic-modifications-in-plc-prf-5-cell-line
#12
JOURNAL ARTICLE
Guiwen Guan, Abudurexiti Abulaiti, Chenxiao Qu, Chia-Chen Chen, Zhiqiang Gu, Jing Yang, Ting Zhang, Xiaojie Chen, Zhao Zhou, Fengmin Lu, Xiangmei Chen
The clearance or transcriptional silencing of integrated HBV DNA is crucial for achieving a functional cure in patients with chronic hepatitis B and reducing the risk of hepatocellular carcinoma development. The PLC/PRF/5 cell line is commonly used as an in vitro model for studying HBV integration. In this study, we employed a range of multi-omics techniques to gain a panoramic understanding of the characteristics of HBV integration in PLC/PRF/5 cells and to reveal the transcriptional regulatory mechanisms of integrated HBV DNA...
April 2024: Journal of Medical Virology
https://read.qxmd.com/read/38647051/cost-effectiveness-of-maribavir-versus-conventional-antiviral-therapies-for-post-transplant-refractory-cytomegalovirus-infection-with-or-without-genotypic-resistance-a-us-perspective
#13
JOURNAL ARTICLE
Bob G Schultz, Camille N Kotton, Ginita Jutlla, Riccardo Ressa, Tam de Lacey, Emtiyaz Chowdhury, Tien Bo, Elisabetta Fenu, Daniele K Gelone, Jean-Etienne Poirrier, Stacey L Amorosi
This study evaluated the cost-effectiveness of maribavir versus investigator-assigned therapy (IAT; valganciclovir/ganciclovir, foscarnet, or cidofovir) for post-transplant refractory cytomegalovirus (CMV) infection with or without resistance. A two-stage Markov model was designed using data from the SOLSTICE trial (NCT02931539), real-world multinational observational studies, and published literature. Stage 1 (0-78 weeks) comprised clinically significant CMV (csCMV), non-clinically significant CMV (n-csCMV), and dead states; stage 2 (78 weeks-lifetime) comprised alive and dead states...
April 2024: Journal of Medical Virology
https://read.qxmd.com/read/38647039/the-prevalence-of-human-immunodeficiency-virus-infection-among-voluntary-blood-donors-in-mainland-china-a-systematic-review-and-meta-analysis
#14
JOURNAL ARTICLE
Yuhui Li, Xinhui Zhang, Yang Huang, Lei Gao, Zhan Gao, Miao He
Human immunodeficiency virus (HIV) infection through transfusion has been an imperative challenge for blood safety. Despite the implementation of screening strategies, there was still the residual risk of transfusion-transmitted HIV. Considering that the prevalence of HIV infection in blood donors is significant for evaluating blood safety and potential risks to the population, meta-analysis was applied to investigate the HIV prevalence among voluntary blood donors during the past 27 years to characterize the epidemiology and related risk factors of HIV in blood donors...
April 2024: Journal of Medical Virology
https://read.qxmd.com/read/38647027/pan-microscopic-examination-of-monkeypox-virus-in-trophoblasts-cells-reveals-new-insights-into-virions-release-through-filopodia-like-projections
#15
JOURNAL ARTICLE
Jonatane Andrieu, Margaux Valade, Marion Lebideau, Florence Bretelle, Jean-Louis Mège, Nathalie Wurtz, Soraya Mezouar, Bernard La Scola, Jean-Pierre Baudoin
Vertical transmission has been described following monkeypox virus (MPXV) infection in pregnant women. The presence of MPXV has been reported in the placenta from infected women, but whether pathogens colonize placenta remains unexplored. We identify trophoblasts as a target cell for MPXV replication. In a pan-microscopy approach, we decipher the specific infectious cycle of MPXV and inner cellular structures in trophoblasts. We identified the formation of a specialized region for viral morphogenesis and replication in placental cells...
April 2024: Journal of Medical Virology
https://read.qxmd.com/read/38644678/sofosbuvir-velpatasvir-in-children-3-17-years-old-with-hepatitis-c-virus-infection
#16
JOURNAL ARTICLE
Maureen M Jonas, Rene Romero, Philip Rosenthal, Chuan-Hao Lin, Gabriella Verucchi, Jessica Wen, William F Balistreri, Suzanne Whitworth, Sanjay Bansal, Daniel H Leung, Michael R Narkewicz, Regino P Gonzalez-Peralta, Alessandra Mangia, Wikrom Karnsakul, Girish S Rao, Jiang Shao, Jan de Jong, Bandita Parhy, Anu Osinusi, Kathryn Kersey, Karen F Murray, Etienne M Sokal, Kathleen B Schwarz
BACKGROUND: The safety and efficacy of sofosbuvir-velpatasvir in children aged 3-17 years with chronic hepatitis C virus (HCV) infection of any genotype were evaluated. METHODS: In this Phase 2, multicenter, open-label study, patients received once daily for 12 weeks either sofosbuvir-velpatasvir 400/100 mg tablet (12-17 years), 200/50 mg low dose tablet or oral granules (3-11 years and ≥17 kg), or 150/37.5 mg oral granules (3-5 years and <17 kg)...
April 21, 2024: Journal of Pediatric Gastroenterology and Nutrition
https://read.qxmd.com/read/38643867/sars-cov-2-mrna-vaccination-and-short-term-changes-in-viral-load-and-cd4-cd8-t-cell-counts-in-people-living-with-hiv
#17
JOURNAL ARTICLE
Alessandra Vergori, Alessandro Cozzi-Lepri, Alessandro Tavelli, Valentina Mazzotta, Anna Maria Azzini, Roberta Gagliardini, Ilaria Mastrorosa, Alessandra Latini, Giovanni Pellicanò, Lucia Taramasso, Francesca Ceccherini-Silberstein, Maddalena Giannella, Evelina Tacconelli, Giulia Marchetti, Antonella d'Arminio Monforte, Andrea Antinori
OBJECTIVES: To investigate if SARS-CoV-2 mRNA vaccination has an impact on HIV-related viro-immunological parameters. METHODS: PWH of the VAXICONA-ORCHESTRA cohort who received ≥1 dose of SARS-CoV-2 mRNA vaccine and for whom paired measures of immuno-virological markers [Viral Load (VL), CD4, CD8 count 1 month before and after a vaccine dose (VD)] were available, were included. Paired t-test and generalized estimating equation linear regression analyses were used to study changes over ± 1 month around the VD...
April 19, 2024: International Journal of Infectious Diseases: IJID
https://read.qxmd.com/read/38643722/evaluation-of-the-analytical-and-clinical-performance-of-two-rt-pcr-based-point-of-care-tests-cepheid-xpert%C3%A2-xpress-cov-2-flu-rsv-plus-and-sd-biosensor-standard%C3%A2-m10-flu-rsv-sars-cov-2
#18
JOURNAL ARTICLE
Christel Barker Jensen, Uffe Vest Schneider, Tina Vasehus Madsen, Xiaohui Chen Nielsen, Chih Man German Ma, Jette Krogh Severinsen, Anne Mette Hoegh, Amanda Bolt Botnen, Ramona Trebbien, Jan Gorm Lisby
BACKGROUND: Rapid and accurate detection of viral respiratory infections is important for infection control measures. This study compares the analytical and clinical performance of the Xpert® Xpress CoV-2/Flu/RSV plus test ("Xpert", Cepheid) and the STANDARD™ M10 Flu/RSV/SARS-CoV-2 test ("M10", SD Biosensor). Both tests are quadruplex RT-PCR assays for rapid diagnosis of SARS-CoV-2, influenza A/B and RSV. STUDY DESIGN: Analytical sensitivities were determined by limit of detection for SARS-CoV-2, influenza A, influenza B and RSV, respectively...
April 16, 2024: Journal of Clinical Virology
https://read.qxmd.com/read/38641844/computational-analysis-of-affinity-dynamics-between-the-variants-of-sars-cov-2-spike-protein-rbd-and-human-ace-2-receptor
#19
JOURNAL ARTICLE
Nishad Sultana, S N Nagesha, C N Lakshminarayana Reddy, B N Ramesh, S Shyamalamma, K S Shashidhara, K M Satish, C Pradeep, G D Vidyadhar
The novel coronavirus SARS-CoV-2 resulted in a significant worldwide health emergency known as the COVID-19 pandemic. This crisis has been marked by the widespread of various variants, with certain ones causing notable apprehension. In this study, we harnessed computational techniques to scrutinize these Variants of Concern (VOCs), including various Omicron subvariants. Our approach involved the use of protein structure prediction algorithms and molecular docking techniques, we have investigated the effects of mutations within the Receptor Binding Domain (RBD) of SARS-CoV-2 and how these mutations influence its interactions with the human angiotensin-converting enzyme 2 (hACE-2) receptor...
April 19, 2024: Virology Journal
https://read.qxmd.com/read/38641833/stability-and-integrity-of-self-assembled-bovine-parvovirus-virus%C3%A2-like-particles-bpv%C3%A2-vlps-of-vp2-and-combination-of-vp1vp2-assisted-by-baculovirus-insect-cell-expression-a-potential-logistical-platform-for-vaccine-deployment
#20
JOURNAL ARTICLE
Ashenafi Kiros Wubshet, Guo-Xiu Li, Qian Li, Jun-Fei Dai, Yao-Zhong Ding, Luoyi Zhou, Min Qu, Yang Wang, Zhongyuan Ma, Gebremeskel Mamu Werid, Birhanu Hadush Abera, Asmelash Tassew Kebede, Yuefeng Sun, Xiangping Yin, Yongsheng Liu, Zhang Jie
BACKGROUND: Bovine parvovirus (BPV) is an autonomous DNA virus with a smaller molecular size and subtle differences in its structural proteins, unlike other animal parvoviruses. More importantly, this virus has the potential to produce visible to silent economic catastrophes in the livestock business, despite receiving very little attention. Parvoviral virus-like particles (VLPs) as vaccines and as logistical platforms for vaccine deployment are well studied. However, no single experimental report on the role of VP1 in the assembly and stability of BPV-VLPs is available...
April 19, 2024: Virology Journal
keyword
keyword
88974
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.